OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
Lianlian Bian, Jianyang Liu, Fan Gao, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 23
Lianlian Bian, Jianyang Liu, Fan Gao, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 23
Showing 23 citing articles:
Dynamic learning for imbalanced data in learning chest X-ray and CT images
Saeed Iqbal, Adnan N. Qureshi, Jianqiang Li, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16807-e16807
Open Access | Times Cited: 18
Saeed Iqbal, Adnan N. Qureshi, Jianqiang Li, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16807-e16807
Open Access | Times Cited: 18
Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant Recipients
Patrick Affeldt, Felix C. Koehler, Karl August Brensing, et al.
Viruses (2022) Vol. 14, Iss. 12, pp. 2646-2646
Open Access | Times Cited: 22
Patrick Affeldt, Felix C. Koehler, Karl August Brensing, et al.
Viruses (2022) Vol. 14, Iss. 12, pp. 2646-2646
Open Access | Times Cited: 22
Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin
Cheng‐Wei Yang, Hsing‐Yu Hsu, Yue‐Zhi Lee, et al.
Biochemical Pharmacology (2023) Vol. 215, pp. 115688-115688
Closed Access | Times Cited: 8
Cheng‐Wei Yang, Hsing‐Yu Hsu, Yue‐Zhi Lee, et al.
Biochemical Pharmacology (2023) Vol. 215, pp. 115688-115688
Closed Access | Times Cited: 8
Effects of Exercise and Physical Activity Levels on Vaccination Efficacy: A Systematic Review and Meta-Analysis
Petros C. Dinas, Yiannis Koutedakis, Leonidas G. Ioannou, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 769-769
Open Access | Times Cited: 10
Petros C. Dinas, Yiannis Koutedakis, Leonidas G. Ioannou, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 769-769
Open Access | Times Cited: 10
Assembly of Immunogenic Protein Particles toward Advanced Synthetic Vaccines
Shuxiong Chen, Diana H. Quan, Gayathri Sam, et al.
Small (2022) Vol. 19, Iss. 8
Open Access | Times Cited: 10
Shuxiong Chen, Diana H. Quan, Gayathri Sam, et al.
Small (2022) Vol. 19, Iss. 8
Open Access | Times Cited: 10
A universal recombinant adenovirus type 5 vector-based COVID-19 vaccine
Xingxing Li, Qinhua Peng, Xinyu Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Xingxing Li, Qinhua Peng, Xinyu Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Platelet dysfunction caused by differentially expressed genes as key pathogenic mechanisms in COVID-19
Xiaoyong TAN, Xiaojun GAO, Huanhuan ZHENG, et al.
Minerva Cardiology and Angiology (2024) Vol. 72, Iss. 5
Closed Access | Times Cited: 1
Xiaoyong TAN, Xiaojun GAO, Huanhuan ZHENG, et al.
Minerva Cardiology and Angiology (2024) Vol. 72, Iss. 5
Closed Access | Times Cited: 1
Anti-COVID-19 Vaccination Alters the Menstrual Cycle and Dose Accumulation Enhances the Effect
Roque D. Licona-Meníndez, Alberto N. Peón
Medicina (2024) Vol. 60, Iss. 6, pp. 956-956
Open Access | Times Cited: 1
Roque D. Licona-Meníndez, Alberto N. Peón
Medicina (2024) Vol. 60, Iss. 6, pp. 956-956
Open Access | Times Cited: 1
Heterologous Omicron-adapted vaccine as a secondary booster promotes neutralizing antibodies against Omicron and its sub-lineages in mice
Jianyang Liu, Qian He, Fan Gao, et al.
Emerging Microbes & Infections (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Jianyang Liu, Qian He, Fan Gao, et al.
Emerging Microbes & Infections (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Mixed formulation of mRNA and protein‐based COVID‐19 vaccines triggered superior neutralizing antibody responses
Jialu Zhang, Qian He, Xujia Yan, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 4
Jialu Zhang, Qian He, Xujia Yan, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 4
Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia
Diego A. Álvarez-Díaz, Ana Luisa Muñoz, María T. Herrera-Sepúlveda, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2144-2144
Open Access | Times Cited: 4
Diego A. Álvarez-Díaz, Ana Luisa Muñoz, María T. Herrera-Sepúlveda, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2144-2144
Open Access | Times Cited: 4
Research of the Spread of Covid-19 in World Wide and Particular Countries
L Zhu, Yifeng Peng, Lancong Xie, et al.
Transactions on Materials Biotechnology and Life Sciences (2024) Vol. 3, pp. 498-505
Open Access
L Zhu, Yifeng Peng, Lancong Xie, et al.
Transactions on Materials Biotechnology and Life Sciences (2024) Vol. 3, pp. 498-505
Open Access
Pan-neutralizing, germline-encoded antibodies against SARS-CoV-2: Addressing the long-term problem of escape variants
Justin Mark Lunderberg, Sanjucta Dutta, Ai‐ris Y. Collier, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Justin Mark Lunderberg, Sanjucta Dutta, Ai‐ris Y. Collier, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Bacterial Artificial Chromosome Reverse Genetics Approaches for SARS-CoV-2
Kevin Chiem, Aitor Nogales, Fernando Almazán, et al.
Methods in molecular biology (2023), pp. 133-153
Closed Access
Kevin Chiem, Aitor Nogales, Fernando Almazán, et al.
Methods in molecular biology (2023), pp. 133-153
Closed Access
Vaccine-induced neutralizing antibodies against SARS-CoV-2 Omicron variant isolated in Osaka, Japan
Satoshi Hiroi, Saeko Morikawa, Kazushi Motomura, et al.
(2022)
Open Access
Satoshi Hiroi, Saeko Morikawa, Kazushi Motomura, et al.
(2022)
Open Access
A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+T cell profile
Gérémy Sannier, Alexandre Nicolas, Mathieu Dubé, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Gérémy Sannier, Alexandre Nicolas, Mathieu Dubé, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Vaccine-induced neutralizing antibodies against SARS-CoV-2 Omicron variant isolated in Osaka, Japan
Satoshi Hiroi, Saeko Morikawa, Kazushi Motomura, et al.
(2022)
Open Access
Satoshi Hiroi, Saeko Morikawa, Kazushi Motomura, et al.
(2022)
Open Access
